Pediatrix Medical Group (MD) Set to Announce Quarterly Earnings on Tuesday

Pediatrix Medical Group (NYSE:MD) is scheduled to be releasing its earnings data before the market opens on Tuesday, May 7th. Analysts expect Pediatrix Medical Group to post earnings of $0.15 per share for the quarter. Parties that wish to listen to the company’s conference call can do so using this link.

Pediatrix Medical Group (NYSE:MD) last posted its quarterly earnings results on Tuesday, February 20th. The company reported $0.32 EPS for the quarter, topping the consensus estimate of $0.30 by $0.02. The firm had revenue of $496.44 million for the quarter, compared to the consensus estimate of $524.30 million. Pediatrix Medical Group had a negative net margin of 3.03% and a positive return on equity of 10.35%. The business’s revenue was down 3.4% compared to the same quarter last year. During the same period last year, the firm posted $0.46 earnings per share. On average, analysts expect Pediatrix Medical Group to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Pediatrix Medical Group Stock Up 2.3 %

NYSE MD opened at $9.33 on Friday. Pediatrix Medical Group has a 1 year low of $7.70 and a 1 year high of $15.02. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.24 and a quick ratio of 1.24. The business’s 50-day moving average is $9.23 and its 200 day moving average is $9.47. The stock has a market capitalization of $784.00 million, a PE ratio of -12.78, a PEG ratio of 2.46 and a beta of 1.58.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on MD shares. Jefferies Financial Group lowered their price target on shares of Pediatrix Medical Group from $10.00 to $9.00 and set a “hold” rating for the company in a research report on Wednesday, March 6th. TheStreet cut Pediatrix Medical Group from a “c” rating to a “d” rating in a research report on Friday, February 23rd. Mizuho decreased their target price on Pediatrix Medical Group from $10.00 to $9.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 21st. Finally, Truist Financial lowered their target price on shares of Pediatrix Medical Group from $10.50 to $10.00 and set a “hold” rating on the stock in a report on Wednesday, February 21st. Five analysts have rated the stock with a hold rating, Based on data from MarketBeat, Pediatrix Medical Group has a consensus rating of “Hold” and an average target price of $9.38.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.